Condensed Statement of Stockholders' Equity - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning Balance, shares at Dec. 31, 2016	17,445,408
Beginning Balance, amount at Dec. 31, 2016	$ 1,745	$ 440,755	$ (234,356)	$ 208,144
Sale of common stock in January 2017 at $0.10447 per share, shares	2,153,754
Sale of common stock in January 2017 at $0.10447 per share, amount	$ 215	224,785		225,000
Shares issued to acquire merger subsidiary to effect reverse recapitalization, shares	400,838
Shares issued to acquire merger subsidiary to effect reverse recapitalization, amount	$ 40	(40)
Sale of common stock in July 2017 at $0.10447 per share, shares	475,000
Sale of common stock in July 2017 at $0.10447 per share, amount	$ 47	49,953		50,000
Sale of common stock in public offering at $1.50 per share in fourth quarter of 2017, net of issuance costs	2,328,533
Sale of common stock in public offering at $1.50 per share in fourth quarter of 2017, net of issuance costs	$ 233	3,422,483		3,422,716
Share-based compensation expense				0
Net loss for the period			(833,545)	(833,545)
Ending Balance, shares at Dec. 31, 2017	22,803,533
Ending Balance, amount at Dec. 31, 2017	$ 2,280	4,137,936	(1,067,901)	3,072,315
Sale of common stock and warrants at $3.00 per share and placement agent warrants in private offering, net of issuance costs, shares	4,561,074
Sale of common stock and warrants at $3.00 per share and placement agent warrants in private offering, net of issuance costs, amount	$ 456	12,140,330		12,140,786
Share-based compensation expense			512,988	512,988
Net loss for the period			(3,336,435)	(3,336,435)
Ending Balance, shares at Dec. 31, 2018	27,364,607
Ending Balance, amount at Dec. 31, 2018	$ 2,736	$ 16,791,254	$ (4,404,336)	$ 12,389,654